Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Murray A. Mittleman, Dr.P.H., M.D., D.Ec.

Co-Author

This page shows the publications co-authored by Murray Mittleman and Robert Glynn.
Connection Strength

0.433
  1. A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data. Clin Pharmacol Ther. 2019 07; 106(1):238-244.
    View in: PubMed
    Score: 0.052
  2. The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation. Epidemiology. 2019 03; 30(2):204-211.
    View in: PubMed
    Score: 0.052
  3. Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis. Drug Saf. 2017 10; 40(10):923-932.
    View in: PubMed
    Score: 0.047
  4. Effects of gestational age at enrollment in pregnancy exposure registries. Pharmacoepidemiol Drug Saf. 2015 Apr; 24(4):343-52.
    View in: PubMed
    Score: 0.039
  5. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol. 2012 Nov; 207(5):405.e1-7.
    View in: PubMed
    Score: 0.033
  6. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013 Jan; 22(1):16-24.
    View in: PubMed
    Score: 0.032
  7. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention. Eur Heart J. 2010 Mar; 31(5):561-72.
    View in: PubMed
    Score: 0.027
  8. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol. 2009 Dec; 62(12):1226-32.
    View in: PubMed
    Score: 0.026
  9. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol. 2009 Dec; 62(12):1233-41.
    View in: PubMed
    Score: 0.026
  10. Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol. 2009 Feb 01; 169(3):273-84.
    View in: PubMed
    Score: 0.025
  11. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
    View in: PubMed
    Score: 0.024
  12. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
    View in: PubMed
    Score: 0.016
  13. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
    Score: 0.016
  14. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.